Norris Medicines Limited (BOM:524414)
India
· Delayed Price · Currency is INR 17.25
+0.17 (1.00%)
At close: Jul 7, 2025
Norris Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 | Upgrade
|
Cash & Short-Term Investments | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 | Upgrade
|
Cash Growth | 5.96% | 84.82% | 9.12% | -10.08% | -67.38% | Upgrade
|
Receivables | 14.09 | 10.61 | 11 | 10.92 | 17.88 | Upgrade
|
Inventory | 41.28 | 43.34 | 32.05 | 24.26 | 53.17 | Upgrade
|
Prepaid Expenses | - | - | - | 0.38 | 0.23 | Upgrade
|
Other Current Assets | 7.66 | 7.11 | 5.95 | 6.98 | 10.84 | Upgrade
|
Total Current Assets | 63.43 | 61.43 | 49.2 | 42.73 | 82.33 | Upgrade
|
Property, Plant & Equipment | 52.68 | 57.86 | 64.69 | 70.69 | 76.71 | Upgrade
|
Long-Term Investments | 0.1 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade
|
Long-Term Deferred Tax Assets | 9.04 | 9.63 | 10.52 | 16.09 | 26.87 | Upgrade
|
Other Long-Term Assets | 12.66 | 12.73 | 12.32 | 12.27 | 11.8 | Upgrade
|
Total Assets | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 | Upgrade
|
Accounts Payable | 30.26 | 17.76 | 13.8 | 13.25 | 52.41 | Upgrade
|
Accrued Expenses | - | 30.57 | 29.83 | 22.51 | 10.16 | Upgrade
|
Short-Term Debt | 30.53 | 29.32 | 29.79 | 29.76 | 28.62 | Upgrade
|
Other Current Liabilities | 40.71 | 14.6 | 3.62 | 2.31 | 25.74 | Upgrade
|
Total Current Liabilities | 101.5 | 92.26 | 77.05 | 67.84 | 116.94 | Upgrade
|
Long-Term Debt | 185.27 | 185.92 | 184.25 | 181.01 | 155.23 | Upgrade
|
Other Long-Term Liabilities | -0 | - | - | 0 | 0 | Upgrade
|
Total Liabilities | 286.77 | 278.17 | 261.3 | 248.85 | 272.17 | Upgrade
|
Common Stock | 99.26 | 99.26 | 99.26 | 99.26 | 99.26 | Upgrade
|
Retained Earnings | -247.93 | -235.56 | -223.69 | -206.2 | -173.56 | Upgrade
|
Comprehensive Income & Other | - | 0 | - | - | - | Upgrade
|
Shareholders' Equity | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 | Upgrade
|
Total Liabilities & Equity | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 | Upgrade
|
Total Debt | 215.81 | 215.24 | 214.04 | 210.77 | 183.85 | Upgrade
|
Net Cash (Debt) | -215.41 | -214.86 | -213.84 | -210.58 | -183.65 | Upgrade
|
Net Cash Per Share | -21.58 | -21.48 | -21.38 | -21.06 | -18.36 | Upgrade
|
Filing Date Shares Outstanding | 9.93 | 10 | 10 | 10 | 10 | Upgrade
|
Total Common Shares Outstanding | 9.93 | 10 | 10 | 10 | 10 | Upgrade
|
Working Capital | -38.07 | -30.83 | -27.84 | -25.11 | -34.61 | Upgrade
|
Book Value Per Share | -14.97 | -13.63 | -12.44 | -10.69 | -7.43 | Upgrade
|
Tangible Book Value | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 | Upgrade
|
Tangible Book Value Per Share | -14.97 | -13.63 | -12.44 | -10.69 | -7.43 | Upgrade
|
Land | - | 5.84 | 5.84 | 5.84 | 5.84 | Upgrade
|
Buildings | - | 58.5 | 58.5 | 58.5 | 58.5 | Upgrade
|
Machinery | - | 213.08 | 215.2 | 214.9 | 214.35 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.